183 related articles for article (PubMed ID: 23990684)
41. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
[TBL] [Abstract][Full Text] [Related]
42. Enzyme replacement therapy reduces Gaucher cell burden but may accelerate osteopenia in patients with type I disease - a histological study.
Rudzki Z; Okoń K; Machaczka M; Rucińska M; Papla B; Skotnicki AB
Eur J Haematol; 2003 May; 70(5):273-81. PubMed ID: 12694162
[TBL] [Abstract][Full Text] [Related]
43. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
Villa G; Balleari E; Carletto M; Grosso M; Clavio M; Piccardo A; Rebella L; Tommasi L; Morbelli S; Peschiera F; Gobbi M; Ghio R
J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
[TBL] [Abstract][Full Text] [Related]
44. [Enzyme replacement therapy in adult patients with type I Gaucher disease].
Ponomarev RV; Lukina EA
Ter Arkh; 2019 Jul; 91(7):127-131. PubMed ID: 32598746
[TBL] [Abstract][Full Text] [Related]
45. Effects of imiglucerase treatment on traumatic fracture and bone and blood abnormalities in a patient with previously untreated type 1 gaucher disease.
Boiret-Dupré N; Descamps S; Coudoré MA; Rapatel C; Kuentz M; Pereira S; Tournadre J; Berger J; Morell P; Berger MG
Clin Ther; 2009 Dec; 31(12):2900-4. PubMed ID: 20110029
[TBL] [Abstract][Full Text] [Related]
46. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
Rosenthal DI; Doppelt SH; Mankin HJ; Dambrosia JM; Xavier RJ; McKusick KA; Rosen BR; Baker J; Niklason LT; Hill SC
Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
[TBL] [Abstract][Full Text] [Related]
47. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients.
Vom Dahl S; Poll L; Di Rocco M; Ciana G; Denes C; Mariani G; Maas M
Curr Med Res Opin; 2006 Jun; 22(6):1045-64. PubMed ID: 16846538
[TBL] [Abstract][Full Text] [Related]
48. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
[TBL] [Abstract][Full Text] [Related]
49. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
[TBL] [Abstract][Full Text] [Related]
50. Radioguided surgery of primary hyperparathyroidism using the low-dose 99mTc-sestamibi protocol: multiinstitutional experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS).
Rubello D; Pelizzo MR; Boni G; Schiavo R; Vaggelli L; Villa G; Sandrucci S; Piotto A; Manca G; Marini P; Mariani G
J Nucl Med; 2005 Feb; 46(2):220-6. PubMed ID: 15695779
[TBL] [Abstract][Full Text] [Related]
51. Individualized long-term enzyme therapy for Gaucher disease type 1 in Slovenia.
Benedik-Dolničar M; Kitanovski L
Pediatr Int; 2011 Dec; 53(6):1018-22. PubMed ID: 21883686
[TBL] [Abstract][Full Text] [Related]
52. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
Drelichman G; Ponce E; Basack N; Freigeiro D; Aversa L; Graciela E; Kohan R
J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
[TBL] [Abstract][Full Text] [Related]
53. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
Heitner R; Arndt S; Levin JB
S Afr Med J; 2004 Aug; 94(8):647-51. PubMed ID: 15352589
[TBL] [Abstract][Full Text] [Related]
54. Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response?
Arikan-Ayyildiz Z; Yüce A; Emre S; Baysoy G; Saltik-Temizel IN; Gürakan F
Turk J Pediatr; 2011; 53(5):499-507. PubMed ID: 22272449
[TBL] [Abstract][Full Text] [Related]
55. Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.
Limgala RP; Ioanou C; Plassmeyer M; Ryherd M; Kozhaya L; Austin L; Abidoglu C; Unutmaz D; Alpan O; Goker-Alpan O
PLoS One; 2016; 11(12):e0168135. PubMed ID: 27942037
[TBL] [Abstract][Full Text] [Related]
56. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
Pastores GM; Elstein D; Hrebícek M; Zimran A
Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
[TBL] [Abstract][Full Text] [Related]
57. [Planar myocardial scintigraphy with technetium-99m-sestamibi in acute myocardial infarct treated with thrombolytic therapy].
Zammarchi A; Pitscheider W; Mautone A; Oberhollenzer R; Lintner W; Erlicher A; Crepaz R; Osele L; Braito E
G Ital Cardiol; 1995 Aug; 25(8):1011-9. PubMed ID: 7498619
[TBL] [Abstract][Full Text] [Related]
58. Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients.
Smid BE; Ferraz MJ; Verhoek M; Mirzaian M; Wisse P; Overkleeft HS; Hollak CE; Aerts JM
Orphanet J Rare Dis; 2016 Mar; 11():28. PubMed ID: 27008851
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi.
Kapucu LO; Akyüz C; Vural G; Oguz A; Atasever T; Büyükpamukçu M; Unlü M
J Nucl Med; 1997 Feb; 38(2):243-7. PubMed ID: 9025746
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic approaches to bone pathology in Gaucher disease: past, present and future.
Goker-Alpan O
Mol Genet Metab; 2011 Dec; 104(4):438-47. PubMed ID: 21889384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
